Privatärztliche Gemeinschaftspraxis Prof. Dr. Augustin & Dr. Scholl, Lichtentalerstr. 1, 76530 Baden-Baden

x

Publikationen in Fachzeitschriften mit Beteiligung von Prof. Dr. Augustin


  1. Haritoglou, Christos; Maier, Mathias; Neubauer, Aljoscha S.; Augustin, Albert J. (2020): Current concepts of pharmacotherapy of diabetic macular edema. In: Expert Opinion On Pharmacotherapy 21 (4), S. 467–475. DOI: 10.1080/14656566.2020.1713093.
  2. Koss, Michael Janusz; Bolz, Matthias; Augustin, Albert J.; Koch, Frank H. J.; Szurman, Peter; Stanzel, Boris V. et al. (2020): Sicherheit, Effektivität und protektive Wirkung einer Parazentese bei intravitrealen Injektionen: „Eine Lanze für die Parazentese brechen“. In: Klinische Monatsblatter fur Augenheilkunde 237 (1), S. 90–94. DOI: 10.1055/a-0972-9747.
  3. Kuppermann, Baruch D.; Patel, Sunil S.; Boyer, David S.; Augustin, Albert J.; Freeman, William R.; Kerr, Kevin J. et al. (2020): Phase 2 Study of the Safety and Efficacy of Brimonidine Drug Delivery System (Brimo DDS) Generation 1 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration. In: Retina (Philadelphia, Pa.). DOI: 10.1097/IAE.0000000000002789.
  4. Panozzo, Giacomo; Cicinelli, Maria Vittoria; Augustin, Albert J.; Battaglia Parodi, Maurizio; Cunha-Vaz, Josè; Guarnaccia, Giuseppe et al. (2020): An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification. In: European Journal of Ophthalmology 30 (1), S. 8–18. DOI: 10.1177/1120672119880394.
  5. Augustin, Albert J. (2019): Buchbesprechung des Buches: Differentialdiagnose in der Augenheilkunde - vom Befund zur Diagnose von Burk A., Burk R. und Kaden R. Verlag: Kaden Verlag. In: Der Ophthalmologe (2), S. 119.
  6. Augustin, Albert J.; Bopp, Silvia; Fechner, Martin; Holz, Frank G.; Sandner, Dirk; Winkgen, Andrea M. et al. (2019): Three-year results from the Retro-IDEAL study. Real-world data from diabetic macular edema (DME) patients treated with ILUVIEN® (0.19 mg fluocinolone acetonide implant). In: European Journal of Ophthalmology, 1120672119834474. DOI: 10.1177/1120672119834474.
  7. Augustin, Albert J.; Feltgen, Nicolas; Haritoglou, Christos; Hoerauf, Hans; Maier, Mathias M.; Mardin, Christian Yahya; Schargus, Marc (2019): Klinische Entscheidungsfindung bei der Behandlung des diabetischen Makulaödems mit DEX-Implantat: ein Konsenspapier. In: Klinische Monatsblatter fur Augenheilkunde. DOI: 10.1055/a-1024-4089.
  8. Dugel, Pravin U.; Campbell, Joanna H.; Kiss, Szilárd; Loewenstein, Anat; Shih, Vanessa; Xu, Xiaoshu; Augustin, Albert J.; et al. (2019): Association between early anatomic response to anti-vascular growth factor therapy and long-term outcome in diabetic macular edema. An Independent Analysis of Protocol I Study Data. In: Retina (Philadelphia, Pa.) 39 (1), S. 88–97. DOI: 10.1097/IAE.0000000000002110.
  9. Fogt, Franz; Rüediger, Thomas; Augustin, Albert J.; Frank, Dale M.; Rosenwald, Andreas; Wellmann, Axel; Lee, Vivian (2019): Isolated Intraocular Rosai-Dorfman Disease. In: Ocular Oncology and Pathology 5 (6), S. 418–423. DOI: 10.1159/000497185.
  10. Kodjikian, Laurent; Bellocq, David; Bandello, Francesco; Loewenstein, Anat; Chakravarthy, Usha; Koh, Adrian; Augustin, Albert J.; et al. (2019): First-line treatment algorithm and guidelines in center-involving diabetic macular edema. In: European Journal of Ophthalmology, 1120672119857511. DOI: 10.1177/1120672119857511.
  11. Rizzo, Stanislao; Barale, Pierre-Olivier; Ayello-Scheer, Sarah; Devenyi, Robert G.; Delyfer, Marie-Noëlle; Korobelnik, Jean-François; Augustin, Albert J.; et al. (2019): Hypotony and the Argus II retinal prosthesis: causes, prevention and management. In: The British Journal of Ophthalmology. DOI: 10.1136/bjophthalmol-2019-314135.
  12. Sadda, Srinivas R.; Campbell, Joanna H.; Dugel, Pravin U.; Holekamp, Nancy M.; Kiss, Szilárd; Loewenstein, Anat; Augustin, Albert J.; et al. (2019): Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data. In: Eye (London, England). DOI: 10.1038/s41433-019-0522-z.
  13. Schaffrath, Kim; Schellhase, Hannah; Walter, Peter; Augustin, Albert J.; Chizzolini, Marzio; Kirchhof, Bernd et al. (2019): One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study. In: JAMA ophthalmology. DOI: 10.1001/jamaophthalmol.2019.1476.
  14. Yoon, Young Hee; Boyer, David S.; Maturi, Raj K.; Bandello, Francesco; Belfort, Rubens, JR; Augustin, Albert J. et al. (2019): Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study). In: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 257 (12), S. 2639–2653. DOI: 10.1007/s00417-019-04464-2.
  15. Augustin, Albert J. (2018): Dexamethasone Intravitreal Implant for Diabetic Macular Edema in Previously Treated Patients. Review. In: Ophthalmology Clinics & Research 1 (1), S. 9–12.
  16. Augustin, Albert J. (2018): EURETINA 2018: Fluocinolone Acetonide Improves Diabetic MAcular Edema Outcomes in Vitrectomized Eyes. Safety outcomes with fluocinolone treatment differed between vitrectomized and non-vitrectomized eyes. In: Eye Care.
  17. Bandello, Francesco; Augustin, Albert J.; Tufail, Adnan; Leaback, Richard (2018): A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion. In: European Journal of Ophthalmology 28 (6), S. 697–705. DOI: 10.1177/1120672117750058.
  18. Di Carlo, E.; Augustin, Albert J. (2018): Pachychoroid Neovasculopathy Within The Spectrum of Pachychoroid Disease. In: Trends in Ophthalmology Open Access Journal 1 (3).
  19. Gregori, Ninel Z.; Callaway, Natalia F.; Hoeppner, Catherine; Yuan, Alex; Rachitskaya, Aleksandra; Feuer, William; Augustin, Albert J.; et al. (2018): Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation. An International Study. In: American Journal of Ophthalmology 193, S. 87–99. DOI: 10.1016/j.ajo.2018.06.012.
  20. Haritoglou, Christos; Maier, Mathias M.; Augustin, Albert J. (2018): Pathophysiology of diabetic macular edema – a background for current treatment modalities. In: Expert Review of Ophthalmology 13 (5), S. 273–281. DOI: 10.1080/17469899.2018.1520634.
  21. Heindl, Ludwig M.; Augustin, Albert J.; Messmer, Elisabeth M. (2018): ADenoVirus Initiative Study in Epidemiology (ADVISE)-results of a multicenter epidemiology study in Germany. In: Graefes Arch Clin Exp Ophthalmol. DOI: 10.1007/s00417-018-4150-2.
  22. Rizzo, Stanislao; Barale, Pierre-Olivier; Ayello-Scheer, Sarah; Devenyi, Robert G.; Delyfer, Marie-Noëlle; Korobelnik, Jean-François; Augustin, Albert J.; et al. (2018): Adverse events of the Argus II retinal prosthesis: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. In: Retina (Philadelphia, Pa.). DOI: 10.1097/IAE.0000000000002394.
  23. Augustin, Albert J. (2017): Intraoperative optische Kohärenztomografie – eine aktuelle Übersicht klinischer Studien zur Anwendung im Vorder- und Hinterabschnitt. In: Klinische Monatsblatter für Augenheilkunde. DOI: 10.1055/s-0042-122710.
  24. Augustin, Albert J. (2017): Retinastabilität – aussagekräftiger Endpunkt bei klinischen Studien zur neovaskulären AMD? (Sponsor Novartis Pharma GmbH). In: BM 04 (03), S. 1–4. DOI: 10.1055/s-0037-1606671.
  25. Gonzalez, Victor H.; Campbell, Joanna H.; Holekamp, Nancy M.; Kiss, Szilárd; Loewenstein, Anat; Augustin, Albert J. et al. (2017): Reply. In: American Journal of Ophthalmology 177, S. 231–232. DOI: 10.1016/j.ajo.2017.02.009.
  26. Meireles, A.; Goldsmith, C.; El-Ghrably, I.; Erginay, A.; Habib, M.; Pessoa, B.; Augustin, Albert J.; et al. (2017): Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy. In: Eye (London, England) 31 (5), S. 684–690. DOI: 10.1038/eye.2016.303.
  27. Steven, Philipp; Augustin, Albert J.; Geerling, Gerd; Kaercher, Thomas; Kretz, Florian; Kunert, Kathleen et al. (2017): Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease. In: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 33 (9), S. 678–685. DOI: 10.1089/jop.2017.0042.
  28. Augustin, Albert J. (2016): Plazenta-Wachstumsfaktor (PlGF) und retinale Gefäßerkrankungen - experimentelle und klinische Datenlage. In: Klinische Monatsblatter für Augenheilkunde 233 (1), S. 57–65. DOI: 10.1055/s-0041-108679.
  29. Augustin, Albert J. (2016): Treatment of Diabetic Macular Oedema – Clinical Trial Findings and Real-world Outcomes Data. In: European Ophthalmic Review 10 (01), S. 31. DOI: 10.17925/EOR.2016.10.01.31.
  30. Augustin, Albert J. (2016): Zwei neue Anwendungen einer etablierten Technologie: Angio-OCTund intraoperatives OCT. DGII-Kongress 2016. In: Ophthalmo Chirurgie 28 (1), S. 25–33.
  31. Gonzalez, Victor H.; Campbell, Joanna H.; Holekamp, Nancy M.; Kiss, Szilárd; Loewenstein, Anat; Augustin, Albert J. et al. (2016): Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data. In: American Journal of Ophthalmology 172, S. 72–79. DOI: 10.1016/j.ajo.2016.09.012.
  32. Augustin, Albert J.; Holz, Frank G.; Haritoglou, Christos; Mayer, Wolfgang J.; Bopp, Silvia; Scheuerle, Alexander F. et al. (2015): Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion. In: Ophthalmologica 233 (1), S. 18–26. DOI: 10.1159/000368840.
  33. Augustin, Albert J.; Kuppermann, Baruch D.; Lanzetta, Paolo; Loewenstein, Anat; Li, Xiao-Yan; Cui, Harry et al. (2015): Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. In: BMC Ophthalmology 15 (1), S. 150. DOI: 10.1186/s12886-015-0148-2.
  34. Dempe, C.; Augustin, Albert J. (2015): Therapie von intraokularen Entzündungen und Bindehautentzündungen. Pharmacotherapy of intraocular inflammation and conjunctivitis. In: Pharmakon 3 (5), S. 378–386.
  35. Pipis, Antonios; Touliou, Eftychia; Pillunat, Lutz E.; Augustin, Albert J. (2015): Effect of the blue filter intraocular lens on the progression of geographic atrophy. In: European Journal of Ophthalmology 25 (2), S. 128–133. DOI: 10.5301/ejo.5000520.
  36. Augustin, Albert J. (2014): Reliable UV-light protection in intraocular lenses--scientific rationale and quality requirements. In: Klinische Monatsblatter für Augenheilkunde 231 (9), S. 901–908. DOI: 10.1055/s-0034-1368566.
  37. Boyer, David S.; Yoon, Young Hee; Belfort, Rubens, JR; Bandello, Francesco; Maturi, Raj K.; Augustin, Albert J. et al. (2014): Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. In: Ophthalmology 121 (10), S. 1904–1914. DOI: 10.1016/j.ophtha.2014.04.024.
  38. Chakravarthy, Usha; Augustin, Albert J.; Yang, Yit; Diestelhorst, Michael; Massin, Pascale (2014): Changing Perspectives in Diabetic Macular Oedema – Recognising and Understanding Chronic Diabetic Macular Oedema. In: European Ophthalmic Review 08 (02), S. 145–151. DOI: 10.17925/EOR.2014.08.02.145.
  39. Coscas, Gabriel; Augustin, Albert J.; Bandello, Francesco; Smet, Marc D. de; Lanzetta, Paolo; Staurenghi, Giovanni et al. (2014): Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. In: European Journal of Ophthalmology 24 (1), S. 1–9. DOI: 10.5301/ejo.5000376.
  40. Augustin, Albert J. (2013): Makulaödem nach retinalem Venenverschluß Dexamethason-Implantat in der Praxis bewährt. In: Der Augenarzt (5).
  41. Augustin, Albert J.; Diehm, Curt; Grieger, Frank; Bentz, Juergen (2013): Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial. In: Expert Opinion on Investigational Drugs 22 (7), S. 803–812. DOI: 10.1517/13543784.2013.794782.
  42. Augustin, Albert J.; Schmit-Eilenberger, Vera Katharina (2013): Early Experience with Iluvien for the Treatment of Chronic DME. In: Retina Today (July/August 2013), S. 34–37.
  43. Augustin, Albert J.; Schmit-Eilenberger, Vera Katharina (2013): Why Do Anti-VEGF Agents Not Work in All Patients with Neovascular AMD? In: Ophthalmology Management (60).
  44. Augustin, Albert J.; Stefánsson, E (2013): Review of the Year: Retina 2013. In: Ophthalmology Times Europe 9 (10), S. 14–15.
  45. Pipis, Antonios; Touliou, Eftychia; Augustin, Albert J. (2013): Macular pigment optical density in a Central European population. In: Ophthalmic Surgery, Lasers & Imaging Retina 44 (3), S. 260–267. DOI: 10.3928/23258160-20130503-09.
  46. Schmit-Eilenberger, Vera Katharina; Augustin, Albert J. (2013): Ocriplasmin opens up new avenues in the therapy of vitreomacular traction. In: Expert Review of Ophthalmology 8 (5), S. 407–411. DOI: 10.1586/17469899.2013.840536.
  47. Augustin, Albert J. (2012): Advanced retinal pigment epithelium analysis by SD-OCT to monitor dry AMD progression. In: Imaging in Medicine 4 (2), S. 251–259. DOI: 10.2217/iim.12.4.
  48. Augustin, Albert J. (2012): Optical Coherence Tomography Imaging and Quantitative Assessment for Monitoring Dry Age-related Macular Degeneration. In: European Ophthalmic Review 06 (02), S. 72. DOI: 10.17925/EOR.2012.06.02.72.
  49. Augustin, Albert J. (2012): Review of the Year: Retina 2012. In: Ophthalmology Times Europe 8 (10), S. 10–11.
  50. Augustin, Albert J.; Sahel, Jose-Alain; Cerulli, Luciano; Texier-Richard, Brigitte; Buchholz, Patricia M.; Kobelt, Gisela (2012): Treating retinal vein occlusions in France, Germany, and Italy: an analysis of treatment patterns, resource consumption, and costs. In: European Journal of Ophthalmology 22 (5), S. 776–784. DOI: 10.5301/ejo.5000180.
  51. Augustin, Constanze; Augustin, Albert J.; Tetz, Manfred; Rizzo, Stanislao (2012): Suprachoroidal Drug Delivery – A New Approach for the Treatment of Severe Macular Diseases. In: European Ophthalmic Review 06 (01), S. 25. DOI: 10.17925/EOR.2012.06.01.25.
  52. Rizzo, Stanislao; Ebert, Federica Genovesi; Di Bartolo, Emanuele; Barca, Francesco; Cresti, Federica; Augustin, Constanze; Augustin, Albert J. (2012): Suprachoroidal drug infusion for the treatment of severe subfoveal hard exudates. In: Retina (Philadelphia, Pa.) 32 (4), S. 776–784. DOI: 10.1097/IAE.0b013e3182278b0e.
  53. Tetz, Manfred; Rizzo, Stanislao; Augustin, Albert J. (2012): Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment results. In: Ophthalmologica 227 (4), S. 183–189. DOI: 10.1159/000336045.
  54. Augustin, Albert J. (2011): Upcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system. In: Expert Opinion on Drug Delivery 8 (2), S. 271–279. DOI: 10.1517/17425247.2011.548802.
  55. Coscas, Gabriel; Loewenstein, Anat; Augustin, Albert J.; Bandello, Francesco; Battaglia Parodi, Maurizio; Lanzetta, Paolo et al. (2011): Management of retinal vein occlusion--consensus document. In: Ophthalmologica 226 (1), S. 4–28. DOI: 10.1159/000327391.
  56. Pipis, Antonios; Scholl, Stefan; Augustin, Albert J. (2011): Emerging drugs for diabetic retinopathy. In: Expert Opinion on Emerging Drugs 16 (4), S. 669–681. DOI: 10.1517/14728214.2011.640673.
  57. Scholl, Stefan; Augustin, Albert J.; Loewenstein, Anat; Rizzo, Stanislao; Kuppermann, Baruch D. (2011): General pathophysiology of macular edema. In: European Journal of Ophthalmology 21 Suppl 6, S. 9. DOI: 10.5301/EJO.2010.6050.
  58. Augustin, Albert J. (2010): Blue Light-Filtering IOLs - Currently available data. In: Klinische Monatsblätter für Augenheilkunde 227 (8), S. 617–623. DOI: 10.1055/s-0029-1245524.
  59. Augustin, Albert J. (2010): Oxidative tissue damage. In: Klinische Monatsblätter für Augenheilkunde 227 (2), S. 90–98. DOI: 10.1055/s-0029-1245125.
  60. Augustin, Albert J.; Loewenstein, Anat; Kuppermann, Baruch D. (2010): Macular edema. General pathophysiology. In: Developments in Ophthalmology 47, S. 10–26. DOI: 10.1159/000320071.
  61. Buchholz, Patricia M.; Buchholz, A. P.; Augustin, Albert J. (2010): Antivascular endothelial growth factor as an approach for macular edema. In: Developments in Ophthalmology 46, S. 111–122. DOI: 10.1159/000320014.
  62. de Groot, Heink; Schmit-Eilenberger, Vera Katharina; Kirchhof, Janna; Augustin, Albert J. (2010): Angiostatic and angiogenic factors. In: Developments in Ophthalmology 46, S. 1–3. DOI: 10.1159/000320005.
  63. Scholl, Stefan; Kirchhof, Janna; Augustin, Albert J. (2010): Antivascular endothelial growth factors in anterior segment diseases. In: Developments in Ophthalmology 46, S. 133–139. DOI: 10.1159/000320016.
  64. Scholl, Stefan; Kirchhof, Janna; Augustin, Albert J. (2010): Pathophysiology of macular edema. In: Ophthalmologica 224 Suppl 1, S. 8–15. DOI: 10.1159/000315155.
  65. Siemerink, Martin J.; Augustin, Albert J.; Schlingemann, Reinier O. (2010): Mechanisms of ocular angiogenesis and its molecular mediators. In: Developments in Ophthalmology 46, S. 4–20. DOI: 10.1159/000320006.
  66. Augustin, Albert J. (2009): Triple therapy for age-related macular degeneration. In: Retina (Philadelphia, Pa.) 29 (6 Suppl), S. 11. DOI: 10.1097/IAE.0b013e3181ad253d.
  67. Augustin, Albert J.; Kirchhof, Janna (2009): Inflammation and the pathogenesis of age-related macular degeneration. In: Expert Opinion on Therapeutic Targets 13 (6), S. 641–651. DOI: 10.1517/14728220902942322.
  68. Augustin, Albert J.; Rizzo, Stanislao (2009): Retina Summit Karlsruhe 2009. In: Expert Review of Ophthalmology (4), S. 223–225.
  69. Augustin, Albert J.; Scholl, Stefan (2009): Combination Therapy for Wet Age-related Macular Degeneration. In: European Ophthalmic Review 03 (02), S. 98. DOI: 10.17925/EOR.2009.03.02.98.
  70. Augustin, Albert J.; Scholl, Stefan; Kirchhof, Janna (2009): Treatment of neovascular age-related macular degeneration: Current therapies. In: Clinical Ophthalmology (Auckland, N.Z.) 3, S. 175–182.
  71. Scholl, Stefan; Kirchhof, Janna; Augustin, Albert J. (2009): Role of inflammation in the pathogenesis of age-related macular degeneration. In: Expert Review of Ophthalmology 4 (6), S. 617–625. DOI: 10.1586/eop.09.51.
  72. Asbell, P.; Prasad, S.; Augustin, Albert J. (2008): Blue- and Violet-Light-Filtering IOLs. CATARACT MINI FOCUS ON HIGH-TECHNOLOGY MONOFOCAL IOLS. In: Cataract & Refractive Surgery Today Europe.
  73. Augustin, Albert J. (2008): The physiology of scotopic vision, contrast vision, color vision, and circadian rhythmicity: can these parameters be influenced by blue-light-filter lenses? In: Retina (Philadelphia, Pa.) 28 (9), S. 1179–1187. DOI: 10.1097/IAE.0b013e3181835885. (Titelseite)
  74. Augustin, Albert J.; Offermann, Indre (2008): Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches. In: Klinische Monatsblätter für Augenheilkunde 225 (6), S. 555–563. DOI: 10.1055/s-2007-963747.
  75. Bandello, Francesco; Augustin, Albert J.; Sahel, Jose-Alain; Benhaddi, Hicham; Negrini, Cristina; Hieke, Klaus; Berdeaux, Gilles H. (2008): Association between visual acuity and medical and non-medical costs in patients with wet age-related macular degeneration in France, Germany and Italy. In: Drugs & Aging 25 (3), S. 255–268.
  76. Augustin, Albert J. (2007): Combination therapy for ocular and tumor angiogenesis. In: Expert Review of Ophthalmology 2 (3), S. 347–350. DOI: 10.1586/17469899.2.3.347.
  77. Augustin, Albert J.; Offermann, Indre (2007): Combination therapy for choroidal neovascularisation. In: Drugs & Aging 24 (12), S. 979–990.
  78. Augustin, Albert J.; Offermann, Indre (2007): Scope and limititions of innovative vitrectomy systems. In: Klinische Monatsblätter für Augenheilkunde 224 (9), S. 707–715. DOI: 10.1055/s-2007-963518.
  79. Augustin, Albert J.; Puls, Stephan; Offermann, Indre (2007): Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone. In: Retina (Philadelphia, Pa.) 27 (2), S. 133–140. DOI: 10.1097/IAE.0b013e3180323de7.
  80. Augustin, Albert J.; Sahel, Jose-Alain; Bandello, Francesco; Dardennes, Roland; Maurel, Frederique; Negrini, Cristina et al. (2007): Anxiety and depression prevalence rates in age-related macular degeneration. In: Investigative Ophthalmology & Visual Science 48 (4), S. 1498–1503. DOI: 10.1167/iovs.06-0761.
  81. Hammes, Stefan; Augustin, Albert J.; Raulin, Christian; Ockenfels, Hans-Michael; Fischer, Edda (2007): Pupil damage after periorbital laser treatment of a port-wine stain. In: Archives of Dermatology 143 (3), S. 392–394. DOI: 10.1001/archderm.143.3.392.
  82. Sahel, Jose-Alain; Bandello, Francesco; Augustin, Albert J.; Maurel, Frederique; Negrini, Cristina; Berdeaux, Gilles H. (2007): Health-related quality of life and utility in patients with age-related macular degeneration. In: Archives of Ophthalmology 125 (7), S. 945–951. DOI: 10.1001/archopht.125.7.945.
  83. Schmidt-Erfurth, Ursula M.; Richard, Gisbert; Augustin, Albert J.; Aylward, William G.; Bandello, Francesco; Corcostegui, Borja et al. (2007): Guidance for the treatment of neovascular age-related macular degeneration. In: Acta Ophthalmologica Scandinavica 85 (5), S. 486–494. DOI: 10.1111/j.1600-0420.2007.00979.x.
  84. Augustin, Albert J. (2006): Anecortave acetate in the treatment of age-related macular degeneration. In: Clinical Interventions in Aging 1 (3), S. 237–246.
  85. Augustin, Albert J. (2006): Blue-filter intraocular lenses. In: Klinische Monatsblätter für Augenheilkunde 223 (2), S. 141. DOI: 10.1055/s-2005-858942.
  86. Augustin, Albert J. (2006): Change of treatment paradigms for wet age-related macular degeneration. In: European Pharmacotherapy (1), S. 1–6.
  87. Augustin, Albert J.; Offermann, Indre (2006): Emerging drugs for age-related macular degeneration. In: Expert Opinion on Emerging Drugs 11 (4), S. 725–740. DOI: 10.1517/14728214.11.4.725.
  88. Augustin, Albert J.; Schmidt-Erfurth, Ursula M. (2006): Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. In: American Journal of Ophthalmology 141 (4), S. 638–645. DOI: 10.1016/j.ajo.2005.11.058.
  89. Augustin, Albert J.; Schmidt-Erfurth, Ursula M. (2006): Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration. In: European Journal of Ophthalmology 16 (6), S. 824–834.
  90. Augustin, Albert J.; Schmidt-Erfurth, Ursula M. (2006): Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. In: Ophthalmology 113 (1), S. 14–22. DOI: 10.1016/j.ophtha.2005.09.002.
  91. Schmidt-Erfurth, Ursula M.; Michels, Stephan; Augustin, Albert J. (2006): Perspectives on verteporfin therapy combined with intravitreal corticosteroids. In: Archives of Ophthalmology 124 (4), S. 561–563. DOI: 10.1001/archopht.124.4.561.
  92. Augustin, Albert J. (2005): Schützen Intraokularlinsen mit Blaulichtfilter die Netzhaut? In: Der Augenspiegel (10), S. 20–22.
  93. Augustin, Albert J.; D'Amico, Donald J.; Mieler, William F.; Schneebaum, Cary; Beasley, Cliff (2005): Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration. In: Graefe's archive for clinical and experimental ophthalmology 243 (1), S. 9–12. DOI: 10.1007/s00417-004-0961-4.
  94. Augustin, Albert J.; Offermann, Indre; Lutz, J.; Schmidt-Erfurth, Ursula M.; Tornambe, Paul (2005): Comparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degeneration. In: Retina (Philadelphia, Pa.) 25 (4), S. 443–445.
  95. Augustin, Albert J.; Dick, H. Burkhard (2004): Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices. In: Journal of Cataract and Refractive Surgery 30 (2), S. 424–427. DOI: 10.1016/S0886-3350(03)00577-7.
  96. Koch, Frank H. J.; Quiroz-Mercado, Hugo; Hattenbach, Lars-Olof; Guerrero-Naranjo, Jose Luis; Yesurun, Itamr; Augustin, Albert J. et al. (2004): Pigment epithelium endoscopic laser surgery for treatment of choroidal neovascularization. In: Ophthalmologica 218 (3), S. 162–175. DOI: 10.1159/000076840.
  97. Augustin, Albert J. (2003): Einfluss der Lichtexposition auf Linse und Makula. In: Ophthalmo-Chirurgie (15), S. 19–25.
  98. Augustin, Albert J. (2003): Kataraktprävention. In: Der Ophthalmologe 100 (3), S. 175. DOI: 10.1007/s00347-003-0795-1.
  99. Augustin, Albert J. (2003): Oxidative Gewebeschäden des Auges. In: Zeitschrift für Praktische Augenheilkunde (24), S. 6–12.
  100. Augustin, Albert J.; Offermann, Indre (2003): Die altersbedingte Makuladegeneration (AMD) (32), S. 114–117.
  101. Augustin, Albert J.; Sekundo, Walter (2003): Refractive laser surgery. The "most topical" theme of the last few years. In: Der Ophthalmologe 100 (8), S. 591–592.
  102. Dick, H. Burkhard; Augustin, Albert J.; Pakula, T.; Pfeiffer, Norbert (2003): Endotoxins in ophthalmic viscosurgical devices. In: European Journal of Ophthalmology 13 (2), S. 176–184.
  103. Grus, Franz H.; Augustin, Albert J.; Loeffler, K. U.; Lutz, J.; Pfeiffer, Norbert (2003): Immunological effects of allopurinol in the treatment of experimental autoimmune uveitis (EAU) after onset of the disease. In: European Journal of Ophthalmology 13 (2), S. 185–191.
  104. Kottler, U. B.; Dick, H. Burkhard; Augustin, Albert J. (2003): Is a cataract avoidable? Current status with special emphasis on the pathophysiology of oxidative lens damage, nutritional factors, and the ARED study. In: Der Ophthalmologe 100 (3), S. 190–196. DOI: 10.1007/s00347-003-0789-z.
  105. Augustin, Albert J. (2002): To peel or not to peel… …and further questions on the management of macular holes. In: Der Ophthalmologe 99 (8), S. 599–600.
  106. Augustin, Albert J.; Dick, H. Burkhard; Koch, Frank H. J.; Schmidt-Erfurth, Ursula M. (2002): Correlation of blood-glucose control with oxidative metabolites in plasma and vitreous body of diabetic patients. In: European Journal of Ophthalmology 12 (2), S. 94–101.
  107. Augustin, Albert J.; Dick, H. Burkhard; Offermann, Indre; Schmidt-Erfurth, Ursula M. (2002): The significance of oxidative mechanisms in diseases of the retina. In: Klinische Monatsblätter für Augenheilkunde 219 (9), S. 631–643. DOI: 10.1055/s-2002-35164.
  108. Augustin, Albert J.; Schmidt-Erfurth, Ursula M. (2002): Critical comments on the ARED study. In: Der Ophthalmologe 99 (4), S. 299–300.
  109. Grus, Franz H.; Sabuncuo, Perihan; Augustin, Albert J.; Pfeiffer, Norbert (2002): Effect of smoking on tear proteins. In: Graefe's archive for clinical and experimental ophthalmology 240 (11), S. 889–892. DOI: 10.1007/s00417-002-0539-y.
  110. Grus, Franz H.; Sabuncuo, Perihan; Dick, H. Burkhard; Augustin, Albert J.; Pfeiffer, Norbert (2002): Changes in the tear proteins of diabetic patients. In: BMC Ophthalmology 2, S. 4.
  111. Grus, Franz H.; Sabuncuo, Perihan; Herber, Simone; Augustin, Albert J. (2002): Analysis of tear protein patterns for the diagnosis of dry eye. In: Advances in Experimental Medicine and Biology 506 (Pt B), S. 1213–1216.
  112. Herber, Simone; Grus, Franz H.; Sabuncuo, Perihan; Augustin, Albert J. (2002): Changes in the tear protein patterns of diabetic patients using two-dimensional electrophoresis. In: Advances in Experimental Medicine and Biology 506 (Pt A), S. 623–626.
  113. Schmidt-Erfurth, Ursula M.; Michels, Stephan; Kusserow, Christine; Jurklies, Bernhard; Augustin, Albert J. (2002): Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results. In: Ophthalmology 109 (12), S. 2284–2294.
  114. Sekundo, Walter; Augustin, Albert J.; Strempel, I. (2002): Topical allopurinol or corticosteroids and acetylcysteine in the early treatment of experimental corneal alkali burns: a pilot study. In: European Journal of Ophthalmology 12 (5), S. 366–372.
  115. Tornambe, Paul; Augustin, Albert J. (2002): Macular holes. Review of the current status of knowledge of pathogenesis and treatment methods. In: Der Ophthalmologe 99 (8), S. 601–608.
  116. Augustin, Albert J. (2001): From the genome to the proteome. In: Der Ophthalmologe 98 (12), S. 1131.
  117. Augustin, Albert J.; Dick, H. Burkhard; Winkgen, Andrea M.; Schmidt-Erfurth, Ursula M. (2001): Cause and prevention of oxidative damage to the eye. Current knowledge. In: Der Ophthalmologe 98 (8), 776-96; quiz 796-7.
  118. Augustin, Albert J.; Dick, H. Burkhard; Winkgen, Andrea M.; Schmidt-Erfurth, Ursula M. (2001): Ursache und Prävention oxidativer Schäden des Auges. In: Der Ophthalmologe 98 (8), S. 776–797. DOI: 10.1007/s003470170090.
  119. Augustin, Albert J.; Keller, A.; Koch, Frank H. J.; Jurklies, Bernhard; Dick, B. (2001): Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patients with proliferative diabetic retinopathy. In: Klinische Monatsblätter für Augenheilkunde 218 (2), S. 89–94. DOI: 10.1055/s-2001-12251.
  120. Dick, H. Burkhard; Augustin, Albert J. (2001): Comparison of intraocular lenses--a review. In: Klinische Monatsblätter für Augenheilkunde 218 (7), S. 469–478. DOI: 10.1055/s-2001-16289.
  121. Dick, H. Burkhard; Augustin, Albert J. (2001): Lens implant selection with absence of capsular support. In: Current Opinion in Ophthalmology 12 (1), S. 47–57.
  122. Dick, H. Burkhard; Frohn, A.; Augustin, Albert J.; Wolters, B.; Pakula, T.; Pfeiffer, Norbert (2001): Physicochemical surface properties of various intraocular lenses. In: Ophthalmic Research 33 (6), S. 303–309.
  123. Dick, H. Burkhard; Kaskel, S.; Höh, Helmut; Augustin, Albert J.; Wehner, W. (2001): Phacoemulsification and vitrectomy with the erbium:YAG laser and phacoemulsification with the neodymium:YAG laser. In: Der Ophthalmologe 98 (9), S. 892–899.
  124. Dick, H. Burkhard; Krummenauer, F.; Augustin, Albert J.; Pakula, T.; Pfeiffer, Norbert (2001): Healon5 viscoadaptive formulation: Comparison to Healon and Healon GV. In: Journal of Cataract and Refractive Surgery 27 (2), S. 320–326.
  125. Dick, H. Burkhard; Olson, R. J.; Augustin, Albert J.; Schwenn, O.; Magdowski, G.; Pfeiffer, Norbert (2001): Vacuoles in the Acrysof intraocular lens as factor of the presence of serum in aqueous humor. In: Ophthalmic Research 33 (2), S. 61–67.
  126. Frohn, A.; Dick, H. Burkhard; Augustin, Albert J.; Grus, Franz H. (2001): Late opacification of the foldable hydrophilic acrylic lens SC60B-OUV. In: Ophthalmology 108 (11), S. 1999–2004.
  127. Grus, Franz H.; Augustin, Albert J. (2001): High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry-eye patients. In: European Journal of Ophthalmology 11 (1), S. 19–24.
  128. Grus, Franz H.; Augustin, Albert J.; Loeffler, K. U.; Dick, B.; Lutz, J.; Pfeiffer, Norbert (2001): Allopurinol has immunomodulating activity following topical and systemic application in experimental autoimmune uveitis. In: European Journal of Ophthalmology 11 (3), S. 252–260.
  129. Grus, Franz H.; Augustin, Albert J.; Pfeiffer, Norbert; Schmidt-Erfurth, Ursula M. (2001): From the genome to the proteome. In: Der Ophthalmologe 98 (12), S. 1132–1137.
  130. Grus, Franz H.; Dick, B.; Augustin, Albert J.; Pfeiffer, Norbert (2001): Analysis of the antibody repertoire in tears of dry-eye patients. In: Ophthalmologica 215 (6), S. 430–434.
  131. Grus, Franz H.; Sabuncuo, Perihan; Augustin, Albert J. (2001): Analysis of tear protein patterns of dry-eye patients using fluorescent staining dyes and two-dimensional quantification algorithms. In: Electrophoresis 22 (9), S. 1845–1850. DOI: 10.1002/1522-2683(200105)22:9<1845::AID-ELPS1845>3.0.CO;2-N.
  132. Grus, Franz H.; Sabuncuo, Perihan; Augustin, Albert J. (2001): Quantitative analysis of tear protein profile for soft contact lenses--a clinical study. In: Klinische Monatsblätter für Augenheilkunde 218 (4), S. 239–242. DOI: 10.1055/s-2001-14920.
  133. Herber, Simone; Grus, Franz H.; Sabuncuo, Perihan; Augustin, Albert J. (2001): Two-dimensional analysis of tear protein patterns of diabetic patients. In: Electrophoresis 22 (9), S. 1838–1844. DOI: 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7.
  134. Pfeiffer, Norbert; Schmidt-Erfurth, Ursula M.; Augustin, Albert J.; Grus, Franz H. (2001): Vom Genom zum Proteom. In: Der Ophthalmologe 98 (12), S. 1132–1137. DOI: 10.1007/s003470170003.
  135. Schmidt, S.; Wessels, L.; Augustin, Albert J.; Klockgether, T. (2001): Patients with Multiple Sclerosis and concomitant uveitis/periphlebitis retinae are not distinct from those without intraocular inflammation. In: Journal of the Neurological Sciences 187 (1-2), S. 49–53.
  136. Sekundo, Walter; Augustin, Albert J. (2001): Differences in the composition of inflammatory cell infiltrate in lens-induced uveitis under therapy with allopurinol or steroids. In: European Journal of Ophthalmology 11 (3), S. 264–268.
  137. Wellmann, Axel; Rohde, V.; Rosenwald, Andreas; Augustin, Albert J. (2001): Of lasers and chips. Key technologies in molecular medicine. In: Der Ophthalmologe 98 (12), S. 1138–1144.
  138. Augustin, Albert J. (2000): Photodynamic therapy with Vsudyne (Verteporfin)--an innovative therapy of age-related macular degeneration. In: Krankenpflege Journal 38 (9-10), S. 342–343.
  139. Augustin, Albert J. (2000): Vitreoretinal Update Meeting 1999. Conference of the American Academy of Ophthalmology, Orlando, Florida, 22-23/10/1999. In: Der Ophthalmologe 97 (2), S. 154–156.
  140. Augustin, Albert J.; Dick, H. Burkhard (2000): Procedure for lens loss into the vitreous body during cataract operation. In: Der Ophthalmologe 97 (9), S. 644–647.
  141. Dick, H. Burkhard; Augustin, Albert J. (2000): Moderne Kataraktchirurgie unter dem Aspekt der Pseudoakkommodation. In: Optometrie (2), S. 13–17.
  142. Dick, H. Burkhard; Augustin, Albert J. (2000): Solvent for removing silicone oil from intraocular lenses: experimental study comparing various biomaterials. In: Journal of Cataract and Refractive Surgery 26 (11), S. 1667–1672.
  143. Dick, H. Burkhard; Augustin, Albert J.; Hessemer, V. (2000): Is oculopression before phacoemulsification in general anesthesia necessary? In: Der Ophthalmologe 97 (11), S. 792–794.
  144. Dick, H. Burkhard; Augustin, Albert J.; Pfeiffer, Norbert (2000): Osmolality of various viscoelastic substances: comparative study. In: Journal of Cataract and Refractive Surgery 26 (8), S. 1242–1246.
  145. Dick, H. Burkhard; Frisch, L.; Augustin, Albert J. (2000): Diagnosis and therapy of diffuse lamellar keratitis. In: Der Ophthalmologe 97 (10), S. 708–712.
  146. Dick, H. Burkhard; Haberern, G.; Kuchenbecker, J.; Augustin, Albert J. (2000): Internet presence and home page design for the ophthalmologist. In: Der Ophthalmologe 97 (7), S. 503–510.
  147. Frohn, A.; Dick, H. Burkhard; Augustin, Albert J.; Grus, Franz H. (2000): Eintrübungen bei Acryllinsen Typ SC60B-OUV der Firma MDR. In: Ophthalmo-Chirurgie 2, S. 173–175.
  148. Grus, Franz H.; Augustin, Albert J. (2000): Protein analysis methods in diagnosis of sicca syndrome. In: Der Ophthalmologe 97 (1), S. 54–61.
  149. Grus, Franz H.; Augustin, Albert J. (2000): Proteinanalytische Methoden bei der Diagnostik des Sikka-Syndroms. In: Der Ophthalmologe 97 (1), S. 54–61. DOI: 10.1007/s003470050012.
  150. Grus, Franz H.; Augustin, Albert J.; Sekundo, Walter; Loeffler, K. U. (2000): Immunological effect of systemically administered allopurinol in experimental autoimmune uveitis. In: Klinische Monatsblätter für Augenheilkunde 216 (3), S. 165–171. DOI: 10.1055/s-2000-10538.
  151. Augustin, Albert J.; Loeffler, K. U.; Sekundo, Walter; Grus, Franz H.; Lutz, J. (1999): Effects of systemically applied allopurinol and prednisolone on experimental autoimmune uveitis. In: Graefe's archive for clinical and experimental ophthalmology 237 (6), S. 508–512.
  152. Grus, Franz H.; Augustin, Albert J. (1999): Analysis of tear protein patterns by a neural network as a diagnostical tool for the detection of dry eyes. In: Electrophoresis 20 (4-5), S. 875–880. DOI: 10.1002/(SICI)1522-2683(19990101)20:4/5<875::AID-ELPS875>3.0.CO;2-V.
  153. Armstrong, D.; Augustin, Albert J.; Spengler, R.; Al-Jada, A.; Nickola, T.; Grus, Franz H.; Koch, Frank H. J. (1998): Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. In: Ophthalmologica 212 (6), S. 410–414.
  154. Augustin, Albert J.; Spitznas, M.; Koch, Frank H. J.; Grus, Franz H.; Lutz, J. (1998): Effects of perfluorooctylbromide and vitamin E on ischemia induced retinal oxidative tissue damage. In: Experimental Eye Research 66 (1), S. 19–24. DOI: 10.1006/exer.1997.0399.
  155. Grus, Franz H.; Augustin, Albert J. (1998): Analysis of the IgG autoantibody repertoire in endocrine ophthalmopathy using the MegaBlot technique. In: Current Eye Research 17 (6), S. 636–641.
  156. Grus, Franz H.; Augustin, Albert J.; Evangelou, N. G.; Toth-Sagi, K. (1998): Analysis of tear-protein patterns as a diagnostic tool for the detection of dry eyes. In: European Journal of Ophthalmology 8 (2), S. 90–97.
  157. Grus, Franz H.; Augustin, Albert J.; Toth-Sagi, K. (1998): Diagnostic classification of autoantibody repertoires in endocrine ophthalmopathy using an artificial neural network. In: Ocular Immunology and Inflammation 6 (1), S. 43–50.
  158. Meller, D.; Augustin, Albert J.; Spitznas, M.; Lutz, J.; Meller, K. (1998): Effects of different perfluorochemicals on dorsal root ganglion cells in vitro. In: Graefe's archive for clinical and experimental ophthalmology 236 (3), S. 182–187.
  159. Reitz, C.; Breipohl, W.; Augustin, Albert J.; Bours, J. (1998): Analysis of tear proteins by one- and two-dimensional thin-layer iosoelectric focusing, sodium dodecyl sulfate electrophoresis and lectin blotting. Detection of a new component: cystatin C. In: Graefe's archive for clinical and experimental ophthalmology 236 (12), S. 894–899.
  160. Augustin, Albert J.; Grus, Franz H.; Koch, Frank H. J.; Spitznas, M. (1997): Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases. In: The British Journal of Ophthalmology 81 (1), S. 58–60.
  161. Blumenröder, S. H.; Augustin, Albert J.; Koch, Frank H. J. (1997): The influence of intraocular pressure and systemic oxygen tension on the intravascular pO2 of the pig retina as measured with phosphorescence imaging. In: Survey of Ophthalmology 42 Suppl 1, S. 26.
  162. Grus, Franz H.; Augustin, Albert J.; Toth-Sagi, K.; Koch, Frank H. J. (1997): Detection and Evaluation of the IgG autoantibody repertoire against human sceletal muscle antigens in Grave´s disease using MegaBlot technique. In: Advances in Therapy (14), S. 8–13.
  163. Grus, Franz H.; Augustin, Albert J.; Zimmermann, C. W. (1997): Computer-supported analysis (MegaBlot) of allopurinol-induced changes in the autoantibody repertoires of rats suffering from experimental lens-induced uveitis. In: Electrophoresis 18 (3-4), S. 516–519. DOI: 10.1002/elps.1150180330.
  164. Grus, Franz H.; Augustin, Albert J.; Zimmermann, C. W.; Spitznas, M.; Sekundo, Walter; Lutz, J. (1997): Immunomodulating activity of allopurinol in experimental lens-induced uveitis. In: Graefe's archive for clinical and experimental ophthalmology 235 (2), S. 118–123.
  165. Koch, Frank H. J.; Luloh, K. Peter; Augustin, Albert J.; el Agha, M. S.; Gümbel, H.; Ohrloff, Christian et al. (1997): Subretinal microsurgery with gradient index endoscopes. In: Ophthalmologica 211 (5), S. 283–287.
  166. Augustin, Albert J.; Grus, Franz H.; Hunt, S. (1996-1997): Effects of allopurinol on free-radical-induced reduction of the proliferation of retinal pigment epithelial cells. In: Documenta Ophthalmologica 93 (3), S. 231–236.
  167. Augustin, Albert J.; Hunt, S.; Breipohl, W.; Böker, T.; Spitznas, M. (1996): Influence of oxygen free radicals and free radical scavengers on the growth behaviour and oxidative tissue damage of bovine retinal pigment epithelium cells in vitro. In: Graefe's archive for clinical and experimental ophthalmology 234 (1), S. 58–63.
  168. Augustin, Albert J.; Spitznas, M.; Sekundo, Walter; Koch, Frank H. J.; Lutz, J.; Meller, D. et al. (1996): Effects of allopurinol and steroids on inflammation and oxidative tissue damage in experimental lens induced uveitis: a biochemical and morphological study. In: The British Journal of Ophthalmology 80 (5), S. 451–457.
  169. Blumenröder, S. H.; Augustin, Albert J.; Spitznas, M.; Koch, Frank H. J.; Grus, Franz H. (1996): Retino-choroidal oxygen imaging through a fundus camera. In: Advances in Experimental Medicine and Biology 388, S. 35–39.
  170. Grus, Franz H.; Augustin, Albert J.; Koch, Frank H. J.; Zimmermann, C. W.; Lutz, J. (1996): Autoantibody repertoires in animals with lens-induced uveitis after different therapies using MegaBlot technique: A comparison. In: Advances in Therapy 13 (4), S. 203–215.
  171. Koch, Frank H. J.; Augustin, Albert J.; Böker, T. (1996): Neuroborreliosis with retinal pigment epithelium detachments. In: German Journal of Ophthalmology 5 (1), S. 12–15.
  172. Koch, Frank H. J.; Augustin, Albert J.; Grus, Franz H.; Spitznas, M. (1996): Effects of different antioxidants on lens-induced uveitis. In: German Journal of Ophthalmology 5 (4), S. 185–188.
  173. Meller, D.; Augustin, Albert J.; Koch, Frank H. J. (1996): A modified technique of impression cytology to study the fine structure of corneal epithelium. In: Ophthalmic Research 28 (2), S. 71–79.
  174. Augustin, Albert J.; Koch, Frank H. J.; Böker, T. (1995): Macular damage following lightning strikes. In: German Journal of Ophthalmology 4 (4), S. 214–216.
  175. Augustin, Albert J.; Spitznas, M.; Kaviani, N.; Meller, D.; Koch, Frank H. J.; Grus, Franz H.; Göbbels, M. J. (1995): Oxidative reactions in the tear fluid of patients suffering from dry eyes. In: Graefe's archive for clinical and experimental ophthalmology 233 (11), S. 694–698.
  176. Augustin, Albert J.; Spitznas, M.; Koch, Frank H. J.; Böker, T.; Lutz, J. (1995): Local effects of different perfluorochemical agents. In: Graefe's archive for clinical and experimental ophthalmology 233 (1), S. 45–47.
  177. Augustin, Albert J.; Spitznas, M.; Koch, Frank H. J.; Böker, T.; Meller, D.; Lutz, J. (1995): Systemic effects of different perfluorochemical agents. In: Graefe's archive for clinical and experimental ophthalmology 233 (1), S. 48–51.
  178. Augustin, Albert J.; Spitznas, M.; Koch, Frank H. J.; Grus, Franz H.; Böker, T. (1995): Indicators of oxidative tissue damage and inflammatory activity in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. In: German Journal of Ophthalmology 4 (1), S. 47–51.
  179. Böker, T.; Augustin, Albert J.; Schmidt, H.; Koch, Frank H. J. (1995): Larger sclerotomies for use of the multiport illumination system do not increase the complication risk of vitrectomy. In: Klinische Monatsblätter für Augenheilkunde 206 (2), S. 78–82. DOI: 10.1055/s-2008-1035408.
  180. Caspari, R.; Olschwang, S.; Friedl, W.; Mandl, M.; Boisson, C.; Böker, T.; Augustin, Albert J.; et al. (1995): Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. In: Human Molecular Genetics 4 (3), S. 337–340.
  181. Koch, Frank H. J.; Cusumano, A.; Seifert, P.; Mougharbel, M.; Augustin, Albert J. (1995-1996): Ultrastructure of the anterior lens capsule after vitrectomy with silicone oil injection. Correlation of clinical and morphological features. In: Documenta Ophthalmologica 91 (3), S. 233–242.
  182. Lutz, J.; Augustin, Albert J.; Jäger, L. J.; Bachmann, D.; Brandl, M. (1995): Acute toxicity and depression of phagocytosis in vivo by liposomes: influence of lysophosphatidylcholine. In: Life Sciences 56 (2), S. 99–106.
  183. Meller, D.; Augustin, Albert J.; Koch, Frank H. J. (1995): Macroaneurysm of a cilioretinal artery. In: German Journal of Ophthalmology 4 (5), S. 320.
  184. Seewald, S.; Kolloch, R.; Klassen, P. M.; Augustin, Albert J.; Böker, T.; Vetter, H. (1995): Progressive loss of vision in suspected tumor. In: Der Internist 36 (1), S. 53–55.
  185. Augustin, Albert J.; Böker, T.; Blumenröder, S. H.; Lutz, J.; Spitznas, M. (1994): Free radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitis. In: Investigative Ophthalmology & Visual Science 35 (11), S. 3897–3904.
  186. Augustin, Albert J.; Böker, T.; Breipohl, W. (1994): Increased lipid peroxides and inflammatory parameters in the retina adjacent to choroidal melanoma. In: The British Journal of Ophthalmology 78 (2), S. 130–132.
  187. Augustin, Albert J.; Böker, T.; Seewald, S.; Klassen, P. M. (1994): Solitary retinal granuloma as a presenting sign of sarcoidosis. In: German Journal of Ophthalmology 3 (2), S. 71–72.
  188. Augustin, Albert J.; Busin, Massimo; Marklein, Gerhard (1994): Sutureless Cataract Surgery can be Sterile Surgery. In: European Journal of Implant and Refractive Surgery 6 (6), S. 351–353. DOI: 10.1016/S0955-3681(13)80211-0.
  189. Augustin, Albert J.; Lutz, J. (1994): Influence of perflubron on the creation of oxygen free radical products in mesenteric artery occlusion shock. In: Artificial cells, blood substitutes, and immobilization biotechnology 22 (4), S. 1223–1230.
  190. Böker, T.; Augustin, Albert J.; Breipohl, W.; Spitznas, M.; Lutz, J. (1994): Increased lipid peroxide level and myeloperoxidase activity in the vitreous of patients suffering from proliferative vitreoretinopathy. In: Graefe's archive for clinical and experimental ophthalmology 232 (11), S. 652–656.
  191. Brandl, M.; Bachmann, D.; Augustin, Albert J.; Jäger, L. J.; Lutz, J. (1994): Depression of the phagocytic activity of the RES by liposomes: Influence of lipids. In: Pharmacological Letters (4), S. 1–4.
  192. Koester, M.; Lutz, J.; Augustin, Albert J.; Meinert, H. (1994): Perfluorodecalin emulsion tested for biocompatibility in macrophages by means of a magnetometric method. In: Artificial cells, blood substitutes, and immobilization biotechnology 22 (4), S. 1231–1236.
  193. Leip, O.; Breipohl, W.; Wegener, A.; Augustin, Albert J. (1994): Distribution pattern of viable mitochondria in bovine lens epithelial cells. In: Developments in Ophthalmology 26, S. 90–96.
  194. Lutz, J.; Augustin, Albert J. (1994): Ischemia reperfusion damage in the gut and its treatment with drugs of the aminosalicylic acid group. In: Advances in Experimental Medicine and Biology 361, S. 327–332.
  195. Augustin, Albert J.; Breipohl, W.; Böker, T.; Lutz, J.; Spitznas, M. (1993): Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinopathy. In: Graefe's archive for clinical and experimental ophthalmology 231 (11), S. 647–650.
  196. Caspari, R.; Friedl, W.; Böker, T.; Augustin, Albert J.; Mandl, M.; Jaeger, K. et al. (1993): Predictive diagnosis in familial adenomatous polyposis: evaluation of molecular genetic and ophthalmologic methods. In: Zeitschrift fur Gastroenterologie 31 (11), S. 646–652.
  197. Augustin, Albert J.; Breipohl, W.; Böker, T.; Wegener, A. (1992): Evidence for the prevention of oxidative tissue damage in the inner eye by vitamins E and C. In: German Journal of Ophthalmology 1 (6), S. 394–398.
  198. Augustin, Albert J.; Göbbels, M. J. (1992): Reversible mydriasis and cycloplegia after isocyanate exposure. In: Klinische Monatsblätter für Augenheilkunde 201 (2), S. 116–118. DOI: 10.1055/s-2008-1045879.
  199. Augustin, Albert J.; Goldstein, R. K.; Milz, J.; Lutz, J. (1992): Influence of anti-inflammatory drugs and free radical scavengers on intestinal ischemia induced oxidative tissue damage. In: Advances in Experimental Medicine and Biology 316, S. 239–251.
  200. Goldstein, R. K.; Augustin, Albert J.; Milz, J.; Burg, G.; Lutz, J. (1992): Influence of free radical scavengers on myeloperoxidase activity and lipid peroxidation in acute skin grafts. In: Advances in Experimental Medicine and Biology 316, S. 253–258.
  201. Lutz, J.; Augustin, Albert J.; Purucker, E.; Milz, J. (1992): Combination of treatment with perfluorochemicals and free radical scavengers. In: Biomaterials, artificial cells, and immobilization biotechnology 20 (2-4), S. 951–958.
  202. Lutz, J.; Augustin, Albert J.; Schwegler, J. S.; Milz, J. (1992): Magnetometric studies on the reticulo-endothelial system of the liver after administration of different lipid emulsions. In: Life Sciences 50 (20), S. 1503–1510.
  203. Lutz, J.; Friedrich, E.; Augustin, Albert J. (1992): Does hyperbaric oxygen treatment, combined with administration of perfluorchemicals cause an unsurmountable exaggeration of damages by oxygen free radicals? In: Physiol Pharmac Acta (28), S. 99–104.
  204. Augustin, Albert J.; Lutz, J. (1991): Intestinal, hepatic and renal production of thiobarbituric acid reactive substances and myeloperoxidase activity after temporary aortic occlusion and reperfusion. In: Life Sciences 49 (13), S. 961–968.
  205. Purucker, E.; Egri, L.; Hamar, H.; Augustin, Albert J.; Lutz, J. (1991): Differences in glutathione status and lipid peroxidation of red and white muscles: alterations following ischemia and reperfusion. In: Research in Experimental Medicine 191 (3), S. 209–217.
  206. Lutz, J.; Augustin, Albert J.; Friedrich, E. (1990): Severity of oxygen free radical effects after ischemia and reperfusion in intestinal tissue and the influence of different drugs. In: Advances in Experimental Medicine and Biology 277, S. 683–690.
  207. Augustin, Albert J.; Hörl, M.; Lutz, J. (1989): Ist Xanthinoxidase die Hauptquelle der Bildung von O2 Radikalen in Ischämiebezirken? In: Zeitschrift für Kardiologie 78 (Supplement 4), S. 83.
  208. Lutz, J.; Augustin, Albert J. (1989): The influence of a temporary cessation and reperfusion of intestinal blood flow on the level of hepatic lipid peroxides. In: Advances in Experimental Medicine and Biology 248, S. 803–808.